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Abstract
Background: The prevalence of heart failure among diabetic patients is high, also in those with normal 
blood pressure and without coronary artery disease, even when electrocardiogram (ECG) is normal. The 
goal of our study was to assess the prevalence of left ventricular diastolic dysfunction (LVDD) among 
diabetic women (DW) and its correlation with glycosylated hemoglobin (HbA1c) levels, obesity status, 
and ECG parameters.
Methods: A group of 456 consecutive normotensive postmenopausal women affected by type 2 diabetes, 
diagnosed over 5 years, were enrolled. One hundred normotensive non-diabetic postmenopausal women 
were included as a control group (CG). Rest ECG and trans-thoracic echocardiogram and Doppler were 
performed.
Results: LVDD was present in 103 (23.3%) out of 456 DW, and 8 out of 100 women in CG (8%),  
p < 0.001. There was no difference in mean age between the two groups: 56 ± 13 and 55 ± 3, respec-
tively (p = 0.3). There were 191 (41.9 %) DW with body mass index (BMI) > 30 kg/m2. Among those, 
there were 56 (12.3%) with significant prevalence of LVDD, while there were 49 (10.7%) with BMI  
< 30 kg/m2, p < 0.005. DW with HbA1c > 7.5% comprised a group of 243 (53.3%) patients. Among 
those, there were 45 (9.9%) with higher prevalence of LVDD, and 15 (3.3%) with HbA1c < 7.5%,  
p < 0.01. Out of a group of 147 (32.2%) DW with abnormal ECG , 21 had LVDD (4.6%), p = 0,1, and 
84 (18.8%) had LVDD with normal ECG.
Conclusions: Our data prove a high prevalence of LVDD in asymptomatic diabetic postmenopausal 
women. This finding is closely related with HbA1c levels and obesity status, not with abnormal ECG, 
which is a unique cardiologic test recommended by current guidelines in all diabetic patients. We con-
clude that early detection of high level of HbA1c and obesity (30 kg/m2) may identify women with major 
risk to develop LVDD. Furthermore, a simple ECG, when normal, is not enough to assess a normal LV 
diastolic function. (Cardiol J 2017; 24, 1: 51–56)
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Introduction
Diabetes mellitus (DM) is the most common 
metabolic disease, especially in Western countries 
and its prevalence will double in the next 25 years [1].
Cardiovascular diseases are the leading cause of 
death among diabetic patients because, as widely dem-
onstrated, chronic hyperglycemia results in morpho-
logical and functional changes on vascular wall, which 
leads to development of atherosclerotic plaque [2].
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It is mandatory to detect “diabetic cardiomyo-
pathy” at an early stage, to improve cardiovascu-
lar risk stratification on diabetic patients. Left 
ventricular (LV) diastolic dysfunction (LVDD), 
without impairment of systolic function, i.e. with 
preserved LV ejection fraction (LVEF), is the first 
stage of “diabetic cardiomyopathy” [3]. The gold 
standard for LVDD assessment is echocardiogram 
with pulse wave (PW) tissue Doppler that allows 
to perform a non-invasive, rapid, free of radiation, 
reproducible assessment of LV filling and pressure 
[4, 5]. Early LVDD of lower degree, as impaired 
relaxation pattern, can be considered a preclinical 
stage of disease, the heart reduces LV compliance 
and elevates filling pressure, increases left atrial 
contribution to LV filling, preserving LVEF [6]. 
It is quite clear that an impaired ventricular re-
laxation can determine, with time, a diastolic heart 
failure with a preserved ejection fraction (heart 
failure with normal ejection fraction, HFpEF), with 
a mortality rate similar to systolic heart failure [7].
Pathogenesis of impaired LV relaxation in dia-
betic patients is not fully understood, although mi-
crovascular disease, autonomic dysfunction, other 
concomitant metabolic disorders, long duration of 
DM and poor blood glucose control are universally 
recognized as concurrent factors [8]. Microcircula-
tion plays an important role in impairment of LV 
compliance, similarly to prolonged hyperglycemia 
causing fibrosis and autonomic dysfunction, with 
an additive and adverse effect of DM on cardio-
vascular system. Mishra et al. [9] found that DM 
represents the most common risk factor involved 
in the development of LVDD [9].
A significant amount of scientific evidence sug-
gests a higher prevalence of LVDD in postmeno-
pausal women [7–10] — a drop in estrogen causes 
a lack in physiological protection of endothelium 
with growth of atherosclerotic plaques and activa-
tion of the renin–angiotensin–aldosterone system 
(RAAS), with increase of angiotensin II and pro-
duction of reactive oxygen species (ROS), with 
impaired ventricular relaxation [11].
It may be observed that in such patients, oc-
cur unfavorable changes in arteries structure and 
function [12]; aortic stiffness is an early marker 
of cardiovascular disease and atherosclerosis, 
[13] whose increase is often associated to ab-
normal LV filling [14]. Therefore, aortic stiff-
ness increases with age and its association with 
mortality is twice higher in women than in men 
[15]. Postmenopausal women present a close 
correlation between aortic stiffness and hyper-
tension, DM and hypercholesterolemia, indepen-
dently of age when the menopause started [16]. 
According to these, aortic stiffness plays a prog-
nostic role in identifying risk of developing adverse 
cardiac events along time.
The goal of our study is to evaluate the preva-
lence of LVDD in asymptomatic and normotensive 
postmenopausal women with DM, over 5 years. 
Our secondary endpoint was the correlation be-
tween LVDD and long-term glycemic control, 
assessed by glycosylated hemoglobin (HbA1c), 
obesity (body mass index [BMI] > 30 kg/m2), being 
LVDD often associated with metabolic disorders.
Methods
Patients
A group of 456 consecutive normotensive 
postmenopausal women affected by type 2 DM over 
5 years were enrolled. Menopause was assessed 
if occurred 12 months after last menstrual period, 
DM duration average time was 7 ± 3 years, all 
of them were on oral antidiabetic therapy, 45 of 
them were also on insulin treatment. Subjects with 
systolic dysfunction (LVEF < 50%), mild-severe 
valvular diseases and atrial fibrillation were exclud-
ed. One hundred normotensive and non-diabetic 
postmenopausal women were included as a con-
trol group (CG). None of the enrolled women was 
physically active. Electrocardiogram (ECG), PW 
tissue Doppler and transthoracic echocardiogram 
(TTE) were performed, baseline characteristics: 
demographic and clinical conditions are described 
in Table I.
The study was approved by the local bioethi-
cal committee and all patients gave their informed 
consent.
Echocardiography
Transthoracic echocardiogram was performed 
with patient in left lateral decubitus, after 10 min 
of resting, with the exam table elevated by 30°. 
The examination was carried out with 3.5 MHz 
probe, with ECG trigger. We used echo-Doppler 
system equipped with a multifrequency transducer, 
GE Vivid T8, Health Care, via Galeno 126, Miland 
(Italy). We assessed: intraventricular septum 
thickness in diastole (IVSd), LV diastolic diameter 
(LVDD), LV posterior wall thickness during dias-
tole (LVPWd), intraventricular septum thickness 
in systole (IVSs), LV systolic diameter (LVSD), LV 
posterior wall thickness during systole (LVPWs), 
ejection fraction (EF), and fractional shortening 
(FS). Peak velocities of early (E wave) and late 
(A wave) trans-mitral flow and deceleration time (DT) 
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were determined, and E/A ratio was calculated. 
LV mass (LVM) was determined according to the 
formula by Devereux et al. [17] and indexed ac-
cording to body surface area (BSA) to obtain LVM 
index (LVMI). Listed normal values of the above 
echocardiogram parameters are in accordance with 
the American Society of Echocardiography. LVDD 
was diagnosed by at least two expert cardiologists 
according to current guidelines [18, 19], by PW 
Doppler of mitral inflow and Doppler tissue imaging 
of the mitral annulus. LVDD was assessed as mild 
or grade I (impaired relaxation pattern), moderate 
or grade II (pseudonormal pattern), and grade III 
or severe (restrictive filling). Mild LVDD for mitral 
E/A ratio < 0.8, DT > 200 ms, IVRT ≥ 100 ms, 
E’< 8 cm/s, E/E’ ratio < 8 (septal and lateral). 
Moderate LVDD for mitral E/A ratio from 0.8 to 
1.5 (pseudonormal), E/E’ (average) ratio from 8 to 
15, and E’< 8 cm/s. Severe LVDD (grade III) for 
E/A ratio ≥ 2, DT < 160 ms, IVRT ≤ 60 ms, E/E’ 
> 15 [18]. All subjects with abnormal diastole, for 
all different degrees of severity, were assessed as 
having LVDD.
Electrocardiogram
It was assessed as abnormal according to ob-
servation of ST-T abnormalities at rest.
Statistical analysis
Statistical analysis was performed by IBM 
SPSS version 20.0 (Chicago, IL, USA). Results are 
described as mean with 95% confidence interval 
(CI 95%). Student’s t test was used  for continu-
ous variables and c2 test for categorical variables. 
A p value < 0.05 was considered significant.
Results
Left ventricular diastolic dysfunction was 
present in 103 (23.3%) out of 456 diabetic 
women (DW), and 8 out of 100 women in CG 
(8%), p < 0.001 (Fig. 1). There was no differ-
Table 1. Baseline characteristics (demographics, diseases and clinical conditions).
Demographic variables All Diabetic Control group P
Age [%] 56 ± 13 55 ± 3 0.3
Postmenopausal women 556 456 100
Body mass index > 30 kg/m2 230 191 (41.9%) 39 (39%) 0.6
HbA1c > 7.5% 234 234 (53.3%) 0 (0%)
Abnormal electrocardiogram 173 147 (32.2%) 26 (26%) 0.1
Figure 1. Left ventricular diastolic dysfunction (LVDD) in postmenopausal (PM) diabetic (D) normotensive women (W) 
according to diabetes status; DM — diabetes mellitus.
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ence in mean age between the two groups: 
56 ± 13 and 55 ± 3, respectively (p = 0.3). 
There were 191 (41.9 %) DW with BMI > 30 kg/ 
/m2. Among those, there were 56 (12.3%) with 
significant prevalence of LVDD, while there were 
49 (10.7%) with BMI < 30 kg/m2, p < 0.005. Then, 
the number of DW with BMI > 30 kg/m2 and nor-
mal diastolic function were 135 (29.6%), DW with 
BMI < 30 kg/m2 and normal diastolic function were 
216 (47.4%). DW with HbA1c > 7.5% comprised 
a group of 243 (53.3%) patients. Among those, 
there were 45 (9.9%) with higher prevalence of 
LVDD, and 15 (3.3%) with HbA1c < 7.5%, p < 0.01. 
A group of 198 (43.4%) DW had poor glycemic con-
trol with normal diastolic function and equally, 198 
(43.4.%) DW had good glycemic control and normal 
diastolic function. Out of a group of 147 (32.2%) 
DW with abnormal ECG, 21 had LVDD (4.6%), 
p = 0,1, and 84 (18.8%) had LVDD with normal 
ECG. Normal diastolic function was found in 126 
(27.7%) DW with abnormal ECG and in 225 (49.3%) 
DW with normal ECG. All results are described 
in Table 2. 105 DW affected by LVDD, 90 were 
on impaired relaxation pattern (85.7%), 84 with 
normal ECG and 6 with abnormal. Eleven (10.4%) 
DW were on pseudonormal pattern and 4 (3.9%) 
on restrictive filling; all 15 DW had abnormal ECG. 
8 women of CG affected by LVDD, all of them had 
abnormal ECG.
Discussion
Our study evaluated the prevalence of LVDD 
in asymptomatic and normotensive postmeno-
pausal women, diabetic over 5 years. We found 
a higher prevalence of LVDD in our diabetic popula-
tion compared with the CG (23.3% for DW vs. 8% for 
CG). Other authors found LVDD as early subclinical 
myocardial damage in diabetic patients [20, 21]. 
Furthermore (Fig. 2), we found a higher prevalence 
Figure 2. Left ventricular diastolic dysfunction (LVDD) in postmenopausal (PM) diabetic (D) normotensive women (W) 
according to different body mass index (BMI) and LVDD.
Table 2. Results according to left ventricular diastolic dysfunction distribution.
Clinical variables Affected Free Control group P
Diabetic women 105 (23.3%) 351 (76.7%) 8 (8%) < 0.001
Body mass index > 30 kg/m2 56 (12.3%) 135 (29.6%) 39 (39%) < 0.005
Body mass index < 30 kg/m2 49 (10.7%) 216 (47.4%)
HbA1c > 7.5% 45 (9.9%) 198 (43.4%) 0 (0%) < 0.01
HbA1c < 7.5% 15 (3.3%) 198 (43.4%) 100 (100%)
Abnormal electrocardiogram 21 (4.6%) 126 (27.7%) 14 (14%) 0.1
Normal electrocardiogram 84 (18.4%) 225 (49.3%) 86 (86%)
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of LVDD in obese women with BMI > 30 kg/ 
/m2 (29.3% for DW vs. 18.4% for CG) and with 
poor glycemic control, assessed by HbA1c > 7.5 
(35.4% for DW vs. 28% for CG) [22]. Bhuiyan 
et al. [23] observed a similar correlation be-
tween LVDD and uncontrolled DM. Our data are 
in accordance with Patil et al. [24], who found 
a strong correlation between LVDD and DM dura-
tion, HbA1c levels, obesity and microcirculation 
impairment. They underline that diabetic patients, 
although asymptomatic, within 10 years since first 
diagnosis, develop microcirculation impairment, 
which leads to cardiovascular events. Several 
mechanisms have been proposed to explain DM and 
LVDD correlation, such as increased cardiac lipid 
accumulation and impaired calcium homeostasis. 
LVDD but not systolic dysfunction was associ-
ated with increased cardiac triglyceride content in 
ob/ob mice [24]. Furthermore, these mice also ex-
hibit impaired calcium reuptake that was associated 
with LV contractile dysfunction [25, 26]. Impaired 
contractility in cardiomyocytes isolated from sed-
entary db/db mice was associated with increased 
diastolic sarcoplasmic reticulum (SR)-Ca2+ leak, 
reduced synchrony of Ca2+ release, lower peak 
systolic and diastolic Ca2+ and caffeine-induced 
Ca2+ release, consistent with a role for calcium in 
the LVDD seen in type 2 DM [27]. This finding is 
in agreement with data concerning Indian popula-
tion, genetically more prone to DM than others. It 
was assessed that LVDD is statistically associated 
with DM duration, poor glycemic control and mixed 
therapy consisting of insulin and oral hypoglycemic 
agents [28].
Another study, on 486 patients affected by 
DM, found that the most important determinant 
of LVDD is DM duration over 4 years, regard-
less of hypertension and coronary artery disease 
affections [29]. Although DM duration seems to 
be a clear determinant for impaired LVDD, the 
prevalence of LVDD in newly-diagnosed (within 
1 month) diabetic patients is high [30]. The preva-
lence of LVDD among diabetic population was 41%, 
lower in women, regardless of confounding factors 
as hypertension, previous ischemia, and obesity. 
Poor glycemic control (HbA1c > 7.24 ± 0.64) 
was statistically associated with LVDD. Age over 
50 years at diagnosis was considered a major risk 
factor for LVDD development. However, in our 
opinion, high LVDD prevalence in newly-diagnosed 
diabetics seems due to a delay in diagnosis. Beyond 
diabetes, there are others determinants of LVDD: 
we found a strong correlation between LVDD and 
hypercholesterolemia in a population of postmeno-
pausal women affected by a mild-moderate hyper-
tension [31]. This finding can be easily explained 
by an increased aortic stiffness and high peripheral 
resistance that compromise LV diastolic function 
in postmenopausal women.
The main finding of this study consists in 
the evaluation of LVDD impact on asymptomatic 
postmenopausal women with normal blood pres-
sure, assessing diabetes as a major determinant 
of LVDD. It is clear that hypertension is the 
most important factor for aortic stiffness, but 
it also plays an important role in determining 
LVDD [32]. Therefore, the diagnosis of LVDD in 
diabetic patients, without a confounding factor 
such as hypertension, requires LVDD monitoring, 
because it represents the first marker of “diabetic 
cardiomyopathy”. Our study has found that poor 
glycemic control and obesity are additional fac-
tors for LVDD increase in diabetic population. 
The evidence of LVDD in diabetic normotensive 
post-menopausal women allows us to affirm that 
a complete echocardiographic examination in all 
diabetics is essential for an early diagnosis of 
“diabetic cardiomyopathy” [33]. LVDD diagnosis 
is often neglected in clinical practice in this sub-
set of patients who are at high risk of developing 
adverse cardiac events. LVDD early diagnosis and 
treatment may be useful to reduce morbidity and 
improve the outcomes.
Conclusions
There is a high prevalence of LVDD in asymp-
tomatic diabetic postmenopausal women; this 
finding is closely related with HbA1c levels and 
obesity status, not with abnormal ECG, which is 
a unique cardiologic test recommended by current 
guidelines in all diabetic subjects. We conclude that 
early detection of high level of HbA1c and obesity 
(30 kg/m2) may identify women with major risk 
to develop LVDD. Furthermore, a simple ECG, 
when normal, is not enough to assess a normal LV 
diastolic function.
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